Trevi Therapeutics, Inc. - COM (TRVI)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
51.5 M
Holdings value Q1 2024
$178 M
Value change Q1 2024
-$5.41 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
77
Number of buys Q1 2024
36
Number of sells Q1 2024
-29
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
89532M101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 51.5 M $178 M -$5.41 K $3.45 77
2023 Q4 49.6 M $66.5 M -$4.4 M $1.34 59
2023 Q3 48.7 M $106 M -$321 K $2.18 54
2023 Q2 48.8 M $117 M +$12.8 M $2.39 52
2023 Q1 43.5 M $80.4 M +$499 K $1.85 35
2022 Q4 43.2 M $83.3 M -$4.14 M $1.93 36
2022 Q3 45.8 M $70.5 M +$26.2 M $1.54 37
2022 Q2 28.8 M $80.8 M +$60.7 M $2.81 31
2022 Q1 7.16 M $15.8 M +$2.08 M $2.20 20
2021 Q4 13.1 M $10.3 M -$220 K $0.78 14
2021 Q3 12.4 M $17.4 M -$64 K $1.40 15
2021 Q2 12.5 M $28.1 M -$1.75 M $2.25 15
2021 Q1 13.1 M $35.6 M +$339 K $2.71 17
2020 Q4 13 M $31.7 M -$645 K $2.42 17
2020 Q3 13.3 M $53.5 M -$728 K $4.03 13
2020 Q2 13.4 M $88 M -$1.32 M $6.58 12
2020 Q1 14 M $45.9 M -$780 K $3.29 17
2019 Q4 14.2 M $53.2 M -$141 K $3.75 15
2019 Q3 14.1 M $63.5 M -$268 K $4.50 17
2019 Q2 14.2 M $106 M +$106 M $7.50 18